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Abstract
The role of caveolin and caveolae in the pathogenesis of infection has only recently been
appreciated. In this chapter, we have highlighted some important new data on the role of caveolin
in infections due to bacteria, viruses and fungi but with particular emphasis on the protozoan
parasites Leishmania spp., Trypanosoma cruzi and Toxoplasma gondii. This is a continuing area
of research and the final chapter has not been written on this topic.
INTRODUCTION
The first steps in the initiation of an infection are the attachment and entry of a pathogen into
a host cell. It has long been assumed that an understanding of these initial events may result
in new methods for control and treatment of infections. A role for caveolae and caveolin
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proteins in these processes has only recently been investigated. In this chapter, it is not our
intent to review all of microbiology and describe how each and every micro-organism
interacts with caveolae and caveolin proteins, but rather to focus our attention on some
recent important new developments. Pathogens enter mammalian cells to escape the immune
system of the host and/or as part of their requirement to maintain a replicative cycle. In the
past several years, this topic has been reviewed by others.1–5 These articles highlighted the
role of caveolae and caveolin proteins, such as caveolin-1 (Cav-1) and lipid rafts in the entry
of diverse pathogens into the host cell. As discussed in detail in other chapters in this book,
Cav-1 is a critical structural protein in the formation of the flask shaped caveolae lining the
plasma membrane. In addition, the role of caveolins in the pathogenesis of infection may be
related to an effect on components of the immune system such as lymphocytes and
macrophages.6,7
VIRUSES
Caveolae are enriched in cholesterol and glycolipids, such as the glycosphingolipid GM1,
glycosylphosphatidylinositol-anchored proteins and caveolin. Caveolae–mediated viral entry
into human cell lines has been described and viruses that enter cells via caveolae apparently
act as signaling ligands, triggering signal transduction events and actin rearrangement in the
host cell, resulting in pathogen uptake (Table 1).8,9
The mechanisms by which a virus gains entry via caveolae are still not completely
understood. The SV40 virus may bind to the MHC Class I complex, which recruits Cav-1 to
the site of viral attachment from preformed caveolae and the associated lipid rafts are then
formed around the virus. Alternatively, the SV40 virus bound to MHC may be associated
with preformed caveolae. Regardless of the precise mechanism, SV40 containing caveolae
pinch off from the plasma membrane and are transported to the endoplasmic reticulum via a
caveosome.8 Polyoma virus, Echovirus, Respiratory Syncitial Virus (RSV) and the
filoviruses (Ebola and Marburg viruses) are additional examples of viruses that are
associated with Cav-1. The effects of lipid raft disrupting agents on Ebola infection indicate
that membrane lipid rafts are important in the entry of filoviruses.1
The HIV-1 receptors are associated with lipid rafts in T-cells and the disruption of the
integrity of these lipid rafts likely inhibits HIV infection. The blood brain barrier (BBB)
integrity is maintained by tight junctions,10,11 and an intact BBB is crucial for preventing
the trafficking of HIV into the brain. Early in the course of HIV infection, virus crosses the
BBB via HIV-1 infected monocytes in macrophages and microglial cells in the brain.
During the subsequent inflammatory response, leukocytes enter into the central nervous
system through breaches in the BBB. Weiss et al 12 demonstrated that HIV-1-Tat protein is a
powerful pro-inflammatory agent that causes transendothelial cell migration of monocytes.
Recently, Zhong et al13 demonstrated that Tat-mediated activation of Ras signaling is
regulated by Cav-1 in brain endothelial cells and that inhibition of Cav-1 and Ras signaling
attenuates Tat-induced disruption of the tight junction proteins.
Papillomaviruses (PVs) infect the mucosal and cutaneous stratified squamous epithelia.
These infections are associated with both benign and malignant neoplasias and the human
papillomaviruses (HPVs) cause virtually all cases of cervical cancer.14 The 8 kb, circular
viral genome is encapsulated by a complex of L1 (major) and L2 (minor) structural
proteins.15 Upon binding to heparan sulfate proteoglycans, the PV capsid undergoes a series
of conformational changes resulting in the N-terminus of L2 becoming sensitive to cleavage
by furin.16 Arecent study suggested that these conformational changes may occur on the
extracellular matrix prior to transfer to the cell.17 Earlier work employed chemical inhibitors
and/or microscopic localization to suggest that HPV16, HPV33, HPV58 and Bovine PV1
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(BPV1) use a clathrin-dependent pathway, whereas similar studies suggest the use of a
caveolae-dependent pathway for HPV31.18–22 However, more recent work suggests that
HPV31 may also use a clathrin-dependent pathway.20 Other authors have suggested that
PVs can enter cells independent of either pathway.23
The lack of in vitro culture methods for the production of infectious virus has limited the
study of PV entry. Most studies have used viral-like particles (VLPs) produced in insect
cells or pseudovirions in which the L1/L2 capsid carries a reporter gene. It is possible that
the use of these laboratory-made particles and nontarget cell lines could explain the
observed differences between entry mechanisms. For example, it has been demonstrated that
HPV16 enters dendritic cells and Langerhans cells via distinct pathways.24
The observations that a simian virus, JC virus (a polyoma virus), enters cells via clathrin-
mediated endocytosis before being shuttled to caveolae-derived vesicles25 led to the
identification of a similar pathway for HPV16 and BPV1.26,27 Based on recent studies,
HPV16 virions first colocalize with markers of early endosomes; then, beginning at around
20 minutes post-entry, increasing amounts of the virons colocalize with Cav-1. Four hours
post-entry the HPV16 virions are present in the endoplasmic reticulum. These observations
strongly suggest that HPV16 and BPV1 enter the host cell via a clathrin-dependent pathway,
after which they get shuttled from endosomes to caveolae. Conversely, HPV31 enters cells
through the caveolar pathway followed by Rab5-dependent shuttling towards endosomes.28
Since Rab5 controls the transport from endosomes to caveosomes and vice-versa, it is
tempting to speculate that both HPV16 and HPV31 could shuttle back and forth between the
caveolar and endosomal pathways following entry. This hypothesis is supported by the
ultrastructural observation that both HPV16 and HPV31 end up in similar looking
vesicles.18 However, studies in which cells have been co-infected with HPV16 and HPV31
have not shown colocalization of both viral types.23 It is possible that the differences in
entry half-time (4 hours for HPV16 vs 14 hours for HPV31) could explain these
observations. Thus, it appears that HPV31 has evolved to (predominantly) enter cells
through a uniquely different pathway from the other tested PV types. This is surprising since
HPV16 and HPV31 are evolutionary more closely related to each other than HPV16 is to
HPV58 or BPV1 (HPV16 and HPV31 share approximately 83% amino acid similarity
(PAM250 matrix) across the L1 structural protein). One hypothesis is that these two highly
related viruses evolved to use different entry mechanisms to avoid competition. However,
the much higher prevalence of HPV16 may suggest otherwise. One key observation is that it
appears that the HPV16-E5 protein up-regulates Cav-1 at the plasma-membrane of cervical
cells. Taken together, these findings suggest that caveolin proteins might play a role in PV
entry, but it will be necessary to sort out discrepant results and intertype differences in order
to adequately assess their role.
BACTERIA
There is limited information regarding the role of caveolins in bacterial infection. However,
early studies suggested that caveolae may be an important alternative pathway for
endocytosis of bacteria.1,2,4,5 Chemical agents have been used to study the function of
caveolae including nystatin, filipin and methyl-β-cyclodextrin (MβCD). These agents
disrupt the cholesterol enriched lipid rafts. Many pathogens require lipid rafts for entry and
colocalize with markers of caveolae to invade host cells. However, only a small number of
bacterial pathogens have actually been shown to require caveolin expression for host cell
entry.
Escherichia coli is an important cause of human infection including those of the urinary and
gastrointestinal tracts. Studies involving E. coli invasion into mast and bladder epithelial
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cells have revealed that caveolae-dependent endocytosis is a mechanism for bacteria to
invade both phagocytic and nonphagocytic cells. Importantly, intracellular bacteria can
colocalize with Cav-1 and compounds that cause disruption of caveolae by removing
membrane cholesterol inhibited bacterial invasion. E. coli uptake and invasion is dependent
on the organization of lipid rafts and Cav-1 expression.29 Furthermore, Campylobacter
jejuni, is an important cause of diarrhea world-wide whose invasion of intestinal epithelial
cells is dependent on Cav-1 expression.30
In an intraperitoneal model of sepsis using lipopolysaccharide injection, Cav-1 null mice
were observed to be resistant to lung injury and their mortality was reduced due to a
reduction in inflammation.31 However, in a Cav-1 null mouse model of Salmonella
typhimirium, an important cause of human diarrhea and systemic illness, Medina etal32
found that higher levels of proinflammatory cytokines, chemokines and nitric oxide
accompanied increased bacterial burden in the spleen. Surprisingly, no differences in S.
typhimurium invasion of macrophages between Cav-1 null or wild type macrophages were
observed.
Infections with Pseudomonas aeruginosa are observed most commonly in hospitalized
immunocompromised individuals, resulting in urinary tract infections, pneumonia and
sepsis. This is especially true of those individuals on mechanical ventilation and those
suffering from severe burns. Also, over 80% of individuals with the genetic disorder Cystic
fibrosis (CF) have pulmonary infection with P. aeruginosa.33 Individuals with CF have a
defect in the transmembrane conductance regulator (CFTR).34,35 In normal individuals,
infection with this bacteria stimulates the formation of lipid rafts that contain the CFTR thus
allowing the organism to invade the respiratory epithelium and initiate inflammatory and
apoptotic processes leading to shedding of bacteria-containing epithelial cells.35–37
However, in CF patients these responses are absent and P. aeruginosa becomes established
as a chronic infection.38 Mechanistically, knockdown of either Cav-1, which also eliminates
Cav-2, or Cav-2 alone reduces the uptake of P. aeruginosa into rat bronchial epithelial
cells.39 Importantly, Bajmoczi et al40 demonstrated that following entry into host cells, P.
aeruginosa colocalizes with Cav-1 and CFTR. More recently, increased mortality, bacterial
burden and inflammation was demonstrated in Cav-1 KO compared with wild type mice,
which correlated with a decreased ability of Cav-1-deficient neutrophils to phagocytose P.
aeruginosa. Additionally, the colonization of P. aeruginosa was more efficient in Cav-1 KO
mice. Taken together, these preclinical observations strongly suggest that Cav-1 contributes




Depending on the species, infection with members of the genus Leishmania may result in
cutaneous, mucocutaneous, or visceral leishmaniasis. These diseases are found wide-spread
in tropical and sub-tropical areas of the world and are major causes of morbidity and
mortality. Additionally, leishmaniasis is an opportunistic infection in patients with HIV/
AIDS.42
Leishmania spp. have a life cycle consisting of two stages, the promastigote and the
amastigote. The extracellular promastigote develops in the gut of the sand fly vector until it
becomes a fully virulent metacyclic promastigote. Metacyclogenesis is a process during
which surface molecules associated with virulence, such as lipophosphoglycan (LPG) and
MSP (called GP63), are modulated in their expression and/or posttranslational
modifications.43–45 Attainment of full promastigote virulence coincides with the feeding
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cycle of the insect vector.43–45 During a blood meal, the sand fly inoculates the parasite in
the skin whereupon it is phagocytosed first by neutrophils and then by macrophages, the
ultimate host cell.46 Inside the macrophage, parasites transform from promastigotes to
amastigotes over two to five days. Thereafter, amastigotes are the only form found in the
mammalian host. Amastigote replication leads to the release of amastigotes from infected
macrophages; amastigotes in turn are taken up by non-infected macrophages, thus spreading
the infection.47,48
Leishmania enter macrophage phagosomes that ultimately fuse with lysosomes. The survival
of Leishmania spp. in this hostile intracellular environment has been primarily attributed to
the capacity of amastigotes to withstand the phagolysosomal compartment and to the ability
of the parasite to down-modulate macrophage activation.49–54 Accumulating evidence
demonstrates that different external stimuli induce distinctive types of macrophage
activation with divergent pro and/or anti-inflammatory profiles.55–57 L. infantum chagasi is
a cause of visceral leishmaniasis. Infection of BALB/c mouse macrophages with L. i chagasi
promastigotes initiates a pattern of gene expression that is neither classically activated nor
alternatively activated, but which demonstrates a novel type of macrophage activation
characterized by an anti-inflammatory profile and an increase in the caveolae-related
molecules dynamin-2, Cav-1 and Cav-3.58 This increase in caveolae components upon L. i.
chagasi infection suggests the presence of a feedback mechanism that may be triggered by
the depletion of surface caveolae upon parasite uptake.
Employing confocal microscopy, virulent L. i. chagasi promastigotes were found to
colocalize with the caveolae markers GM1 and Cav-1 both during entry and up to 24 hours
after murine macrophage infection (Fig. 1). Entry of promastigotes via Cav-1 correlated
with a delay in lysosome fusion of approximately 24 to 48 hours; a time coinciding with
their promastigote-to-amastigote conversion.48,59 Colocalization of promastigotes with
Cav-1 also correlated with increased parasite survival. In contrast, serum opsonization of
attenuated (avirulent) L. i. chagasi promastigotes precluded parasites to enter macrophages
through lipid rafts/caveolae. Unlike virulent L. i. chagasi, avirulent parasites entered
compartments that fused early with lysosomes usually within the initial three hours of
infection and failed to survive in macrophages.
Because caveolae are enriched in cholesterol, transient treatment of macrophages with the
cholesterol chelating agent MβCD was used to investigate the role of lipid rafts/caveolae in
Leishmania infection. MβCD treatment does not affect macrophage viability if the cell
membrane cholesterol is extracted while preserving the intracellular cholesterol pools.59–61
Under these conditions, pretreatment with MβCD significantly impaired parasite entry and
inhibited replication for up to 72 hours after phagocytosis, even though surface cholesterol
was restored by 4 hours after treatment. Furthermore, macrophage pretreatment with MβCD
accelerated the rate of lysosome fusion and led to rapid intracellular killing. Side by side
comparisons showed that transient disruption of lipid rafts/caveolae caused virulent
metacyclic L. i. chagasi to enter macrophages through a phagocytic pathway, leading to
early lysosome fusion and intracellular death, resembling the entry of attenuated parasites.59
Surface LPG and MSP on metacyclic promastigotes are able to bind and inactivate the
serum protein C3b to C3bi, facilitating parasite uptake through the macrophage receptor
CR3, which localizes in caveolae.62–65 A comparison of the receptors used by avirulent log
phase versus virulent metacyclic L. i. chagasi in human macrophages demonstrated that
metacyclic parasites preferentially enter through CR3 but not the mannose receptor and that
the metacyclic parasites colocalize with Cav-1 during the initial hour of infection. In
contrast, log-phase parasites ligated both the mannose receptor and CR3 and failed to
colocalize with Cav-1. The ability of metacyclic, but not log phase promastigotes to
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associate with CR3 and Cav-1 also correlated with a slower kinetics of lysosome fusion and
increased parasite survival.66
The amastigote form of the parasite expresses low levels of MSP and no LPG; the latter of
which inhibits lysosome fusion with promastigotes. Amastigotes can survive in the
phagolysosomes and it has been suggested that the unique nutritional requirements of the
amastigote can only be met in this degradative compartment.67–69 As such, amastigotes
might not benefit from entering macrophages through a cholesterol-rich/caveolae uptake
mechanism that delays lysosome fusion. Indeed, side by side experiments with metacyclic
promastigotes and hamster-derived amastigotes of L. i. chagasi supported this hypothesis.
Transient depletion of cholesterol from BALB/c mouse macrophages did not affect the entry
of amastigotes or their kinetics of lysosome fusion (submitted manuscript, Rodriguez, Gaur,
Allen and Wilson), suggesting that the entry and survival of amastigotes is independent of
cholesterol-rich microdomains including caveolae. Taken together, these results suggest that
virulent, but not attenuated or log phase promastigotes, are able to exploit a caveolae-
mediated pathway to facilitate their entry and intracellular survival by a mechanism that
includes delayed lysosome fusion until their conversion into amastigotes and the
establishment of infection.
Trypanosoma cruzi
Trypanosoma cruzi causes Chagas’ disease. It is an important cause of acute myocarditis,
chronic cardiomyopathy and gastrointestinal disorders in endemic areas.70 Chagas’ disease
is found in endemic areas of Mexico, Central and South America. In recent years, there has
been an increased recognition of Chagas’ disease among immigrants from endemic areas
into North America and Europe. Chagas’ disease is also an opportunistic infection in
patients with HIV/AIDS.71–73
The parasite has a complex life cycle. During a blood meal from an infected mammalian
host, the insect vector ingests blood-form trypomastigotes, which undergo transformations
and after 3 to 4 weeks, infective, nondividing metacyclic trypomastigotes are present in the
hindgut of the vector and are deposited with the feces of the vector during subsequent blood
meals. Transmission to the new host occurs when the parasite-laden feces contaminate oral
or nasal mucous membranes, the conjunctivas, or other vulnerable surfaces. Other modes of
transmission include blood transfusion, organ donation, congenital, breast milk, ingestion of
contaminated food or drink and laboratory accident.
When the trypomastigotes enter a host cell they transform into amastigotes where they
multiply by binary fission and again transform to trypomastigotes. Trypomastigotes are
released as the host cell ruptures and disseminate through the lymphatics and the
bloodstream to find new cells to invade. The precise mechanism(s) by which the parasite
enters the host cell is not entirely understood, however several receptors have been
implicated in this process. Although any nucleated mammalian cell can be parasitized, those
of the cardiovascular system, including cardiac myocytes, cardiac fibroblasts, endothelial
cells and vascular smooth muscle cells, as well as cells of the reticuloendothelial, nervous
and muscle systems and adipose tissue, appear to be favored.
T. cruzi infection is characterized by an intense inflammatory reaction accompanied by an
upregulation of cytokines and chemokines.73,74 Pathological examination of the
cardiovascular system in both human samples and experimental acute chagasic myocarditis
reveals inflammation, myonecrosis, vasculitis and numerous parasite pseudocysts. In
chronic chagasic cardiomyopathy, inflammation, fibrosis, myocytolysis and vasculitis
persist but there are few parasites in the infected tissues. In many chronically infected
individuals there is a dilated cardiomyopathy. In order to understand the mechanisms
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involved in progression of disease and the development of the resulting cardiomyopathy,
many groups have focused their research either on the in vitro infection of cardiac cells with
T. cruzi or through the use of murine models of infection.
Caveolin is a negative regulator of extracellular signal-regulated kinases (ERK) and cyclin
D1.75 Thus, a reduction in the expression of Cav-1 and Cav-3 generally results in the
upregulation of ERK activity and an induction of cyclin D1 expression, which contribute to
cardiac myocyte hypertrophy and ultimately cardiomyopathy. Interestingly, Cav-1 and
Cav-3 null mice as well as the Cav-1/Cav-3 double null mice display a cardiomyopathic
phenotype associated with cardiac myocyte hypertrophy and interstitial fibrosis.76–78 Thus,
it was of great interest that during the acute phase of T. cruzi infection a reduction in the
expression of Cav-1, Cav-2 and Cav-3 was observed. This was accompanied by activation of
ERK, activator protein 1 (AP-1), nuclear factor kappa-light-chain-enhancer of activated B
cells (NF-κB) and increased cyclin D1 expression.79,80 The change in Cav-1 expression in
infected mice was the result in part of infection of the cardiac fibroblasts since cardiac
myocytes do not express Cav-1. At 60 days post-infection, which is considered the sub-
acute/chronic phase, there was a reduction in Cav-3 expression which normalized by day
180 post-infection,81 though the increase in the expression of ERK persisted. Thus, it would
appear that the initial reduction in Cav-3 expression may trigger an increase in ERK, leading
to cardiac myocyte hypertrophy.
Chagas’ disease is also a vasculopathy and in carotid arteries obtained from T. cruzi infected
mice there was a reduction in the expression of Cav-1 and Cav-3 and activation of ERK,
cyclin D1 and endothelin-1(ET-1).82 These findings may in part explain the vasoconstriction
observed as a result of this infection. T. cruzi infection also results in a reduction of Cav-1
and Cav-2 expression and an increase in activated ERK, cyclin Dl and ET-1.82,83 In
addition, infection of cardiac myocytes results in a reduction of Cav-3 expression and a
concomitant increase in activated ERK (Fig. 2).81 Taken together T. cruzi infection results
in cardiomyopathy and a vasculopathy in which caveolin, ERK, cyclin D1 and ET-1
contribute to cardiovascular remodeling and the pathogenesis of chagasic heart disease.
Employing the highly virulent Tulahuen strain of T. cruzi infection, Medina et al84 infected
both Cav-1 wild type and Cav-1 null mice and while the resulting mortality was 100% in
both genetic backgrounds, death was slightly delayed in the wild type mice. The parasitemia
in the Cav-1 null mice was significantly reduced compared with wild type mice. In both
groups there were numerous pseudocysts, myonecrosis and marked inflammation.
Interestingly, infection of cultured cardiac fibroblasts obtained from Cav-1 null and wild
type mice revealed no differences in infectivity. Determination of serum levels of several
inflammatory mediators revealed a significant reduction in IFN-γ, TNF-α and components
of the nitric oxide pathway in infected Cav-1 null mice, while infection of wild type mice
resulted in an increase in these inflammatory mediators. The defective production of
chemokines and cytokines observed in vivo is, in part, attributed to Cav-1 null macrophages.
These results suggest that Cav-1 may play an important role in the normal development of
immune responses. Recently, Barrias et al demonstrated that infection of mouse peritoneal
macrophages with the Y strain of T. cruzi was impaired when cells were treated with
MβCD.85 The contributions of caveolin in Chagas’ disease are not entirely understood and
investigators are continuing to explore these interactions.
Toxoplasma gondii
Toxoplasma gondii is a ubiquitous Apicomplexan obligate intracellular protozoan parasite
of mammals and birds. It has long been recognized as being an important cause of
congenital infection with chorioretinitis and central nervous system manifestations and has
also emerged as an opportunistic pathogen in immune compromised hosts where it primarily
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causes encephalitis.86–88 Although overwhelming disseminated toxoplasmosis has been
reported, the predilection of this parasite for the central nervous system causing necrotizing
encephalitis and the eye causing chorioretinitis constitutes its major threat to patients. The
development of these diseases is a consequence of the transition of the resting or latent
bradyzoite stage to the active rapidly replicating form, the tachyzoite stage.86–87,89–93 It is
likely that in chronic toxoplasmosis tissue cysts (bradyzoites) regularly transform to
tachyzoites and that these active forms are removed or sequestered by the immune system,
while some invade host cells differentiating to new tissue cysts.86,89,90,93
T. gondii replicates within a parasitophorous vacuole, isolated from host vesicular traffic.94
T. gondii are capable of actively invading host cells95,96 and these invasion processes
require parasite motility, orientation toward the host cell and sequential discharge of three
secretory organelles termed micronemes, rhoptries and dense granules.97,98 Host cell
cholesterol is required for entry and intracellular replication of this and other
pathogens.99–102 Central roles for cholesterol are suggested at the attachment, penetration
and intracellular multiplication stages. Depletion of membrane cholesterol leads to a loss of
invaginated caveolae.103 The predominant sterol in T. gondii membranes is cholesterol and
it has been unequivocally demonstrated that this parasite is auxotrophic for this major
lipid.101 T. gondii actively intercepts low-density lipoprotein (LDL)-derived cholesterol that
has transited through host lysosomes by a yet undefined mechanism. Cholesterol trafficking
from mammalian lysosomes to intravacuolar T. gondii requires functional host Niemann–
Pick type cholesterol proteins (NPC), which are known to mediate cholesterol egress across
the endosomal (mainly NPC1) and lysosomal (mainly NPC2) membranes,104 and trafficking
is independent of pathways involving the host Golgi and endoplasmic reticulum.101 The
uncoupling between LDL uptake and cholesterol biosynthesis occurring during T. gondii
infection101 leads to the assumption that these pathways are dramatically perturbed in
infected cells.
Caveolae/caveolins have been proposed to function in a number of cholesterol-trafficking
steps. These steps include selective cholesterol uptake from HDL via the scavenger receptor
SR-B1 located in caveolae (cholesterol influx) and the delivery of newly synthesized
cholesterol from the endoplasmic reticulum membrane caveolae, where it is delivered to
HDL (cholesterol efflux).105 However, studies have shown that high levels of host caveolae
vesicles are not needed for trafficking of LDL-derived lysosomal cholesterol to Toxoplasma
in mammalian cells.101 It has been suggested that a probable scenario during T. gondii
infection is that following LDL receptor-mediated endocytosis, cholesterol is liberated from
LDL cholesteryl ester in early hydrolytic compartments containing the enzyme acid lipase.
The cholesterol then effluxes from the NPC-containing late endosome/lysosome before
trafficking to the parasitophorous vacuole. The post-endolysosomal movement of
cholesterol to the parasitophorous vacuole is blocked by inhibitors of vesicular transport but
does not require vesicle fusion or host endolysosome fusion with the parasitophorous
vacuole. Transit to the parasitophorous vacuole is direct, rather than across host organelles,
e.g., endoplasmic reticulum, Golgi101,106 or through the host plasma membranes.107
However, the parasitophorous vacuole is accessible to sterol acceptors in the medium by an
unknown mechanism. Neither the host sterol carriers SCP-2 nor caveolins are involved and
the process is independent of vimentin intermediate filaments. Host cholesterol is delivered
to the parasitophorous vacuole via lipid extractor-or transporter-like proteins on the
parasitophorous vacuole membrane, then trafficked within the vacuolar space, perhaps in
association with the tubulo-vesicular network (TVN) secreted by T. gondii before
internalization into the parasite interior via parasite plasma membrane proteins and storage
as cholesteryl esters in lipid bodies.
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Rhoptries are elongated club-shaped organelles containing a densely packed granular
material in their basal bulbous portion and are related to secretory lysosomes or
exosomes.108 T. gondii rhoptries are formed via the endocytic pathway109 and contribute to
the formation of the Toxoplasma and Plasmodium parasitophorous vacuole membranes
(PVMs) by releasing their contents from the anterior end of the parasite during
invasion.98,110,111 Toxoplasma rhoptries also contain lipids, including large amounts of
cholesterol and phosphatidylcholine.112,113 In these organelles, the cholesterol/phospholipid
molar ratio (1.5/1) is too high for lipid bilayer stability, suggesting that some rhoptry
cholesterol molecules may be organized in a crystalline array inside the organelle. Although
it is plausible that rhoptry cholesterol is incorporated into the PVM during invasion and that
rhoptry discharge can effectively compensate for the absence of caveolae in host cells, this
possibility requires testing.
The biogenesis of the PVM surrounding Toxoplasma is only partially understood.
Capacitance measurements in patch-clamped host cells indicate that at least 80% of the
membrane in the nascent vacuolar membrane is host cell derived.114 This is consistent with
observations showing that fluorescent tracers inserted into the host plasma membrane before
infection were incorporated into the nascent PVM of Toxoplasma110,115,116 as well as into
the Plasmodium PVM.117 Additionally, multiple lines of evidence suggest that rhoptry
contents contribute directly to formation of the vacuolar membrane.109,110,118–120 These
apparently conflicting observations can be resolved by postulating a two-step process of
invasion. Initial discharge of the rhoptry contents directly into the host cytoplasm leads to
coalescence of multivesicular structures, which then fuse with the nascent vacuole that is
derived primarily from the host cell plasma membrane.121 Whether and how cholesterol
contributes to this unusual process of cell invasion by T gondii is not clear. Studies have
evaluated the ability of cholesterol-depleted parasites to invade normal cells, of cholesterol-
depleted cells to be invaded by untreated parasites, as well as the ability of normal parasites
to invade caveolin-minus cells. The results demonstrate that T gondii is dependent upon host
plasma membrane cholesterol to trigger organelle discharge. Neither rhoptry-derived
cholesterol nor caveolae microdomains in the host cell plasma membrane are required to
complete invasion. These results identify a heretofore unexpected mechanism by which
cholesterol regulates microbial entry into mammalian cells.
Lisanti and colleagues122,123 discovered that purified caveolae microdomains contained an
abundance of signaling molecules, such as Src-like tyrosine kinases and heterotrimeric G
proteins and proposed that Cav-1 and caveolae may serve as docking points for numerous
cell surface receptors, which, when activated by ligand binding, are recruited to
caveolae.122,123 It has been demonstrated that GTPase activity of G protein-subunits could
be suppressed by a peptide derived from the NH2 terminus of Cav-1 termed the caveolin
scaffolding domain, demonstrating the interdependence of these proteins for functional
activity.124 Finally, studies have shown that interaction of the T. gondii-derived molecule
cyclophillin-18 (C-18) with a chemokine receptor (CCR5) on dendritic cells is critical for
IL-12 (a pro-inflammatory mediator) induction in vivo and the subsequent control of
parasite growth.125 Since CCR5 is associated with G-protein-subunits, it is interesting to
consider the possible participation of caveolin in the signaling pathways and transcriptional
events downstream of CCR5 triggered by T gondii.
FUNGI
Although significant efforts have led to an appreciation that sterol-rich membrane domains
significantly impact the function of fungal membranes,126 there is limited information
regarding the role of lipid rafts and caveolae in the pathogenesis of fungal disease in
mammalian hosts. The most in depth analysis of a fungal interaction with cellular membrane
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rafts comes from a study on Paracoccidioides brasiliensis, a dimorphic fungus endemic in
the environment in Central and South America.125 This fungus causes a spectrum of human
disease ranging from mild localized infection to disseminated deep lesions, characterized by
granulomatous inflammation. P. brasiliensis is frequently acquired via inhalation. Using
epithelial alveolar cells, Maza et al127 demonstrated that host cell lipid rafts are critical for
engaging P. brasiliensis cells. They demonstrated that ganglioside GM1 appeared to be
recruited to the point of adhesion of P. brasiliensis to this host cell. Furthermore,
pretreatment of the alveolar cells with either MβCD to deplete host cell cholesterol, or
nystatin, to bind host cholesterol, significantly reduced fungal adhesion.
Pneumocystis species are frequent pulmonary pathogens in hosts with compromised cellular
immune responses, especially individuals with AIDS and the fungus can intimately engage
Type I alveolar epithelial cells.128 Although Pneumocystis associates with cells, the fungus
is an extracellular pathogen. Nevertheless, the fungus interdigitates with the alveolar cells
and activates caveolae of the host cells, resulting in the close proximity of plasmalamellar
vesicles in the areas of contact. Presumably, this allows the fungus to parasitize the host
cells for nutrients.
Beta-glucans are major components of many fungal cell walls including that of Candida
albicans, which is the most prevalent cause of systemic mycoses. Beta-glucans from C.
albicans can interact with very long fatty acid-containing lactosylceramide lipid rafts on the
plasma membrane of human neutrophils, inducing migration of the neutrophil toward the
fungus129,130 and, presumably, enhancing phagocytosis of the yeast.
Histoplasma capsulatum, a dimorphic fungus endemic to the Mississippi and Ohio River
Valleys of the USA and in regions within Central and South America, causes pulmonary and
disseminated infections, especially in individuals with compromised immunity. Calcium
binding protein (CBP) is a well known virulence factor for the fungus that recently was
shown to have structural homology with mammalian saposin B.131 Hence, it has been
proposed that CBP may interact with host glycolipids, including those present in caveolae.
This finding underscores the probable broad and yet undiscovered import of caveolae in
interactions with pathogenic fungi. Future work will continue to elucidate the functional
importance of caveolae interactions with fungi during adhesion, internalization and internal
processing.
CONCLUSION
A growing list of pathogens, including viruses, bacteria and their associated toxins, fungi
and even prions, can interact with caveolae membrane domains.2 The intracellular
trafficking of these agents via caveolae differs dramatically from the usual route of ligands
internalized by clathrin-mediated endocytosis. The use of caveolae for cellular entry allows
the pathogen to avoid classical endosome-lysosome trafficking and, consequently, avoid
degradative compartments within the cell.
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Intracellular L. i. chagasi colocalizes with caveolin-1. Bone marrow macrophages were
infected with carboxy-fluorescein diacetate succinimidyl (CFSE) labeled L. i. chagasi
promastigotes (green). Macrophage and parasite DNA was stained with TO-PRO-3 (blue).
Confocal microscopy was used to assess colocalization of markers at serial time points.
Caveolin-1 (red) clustered at the entry site of L. i. chagasi promastigotes and remained
associated with parasites for 24 to 48 hours after infection. Shown is a picture taken at 24
hours of infection. Scale bar: 5 μm. A color version of this image is available online at
www.landesbioscience.com/curie. Reproduced with permission from Adesse et al. Cell
Cycle 2010; 9:1639–1649.81
Machado et al. Page 18








Caveolin-3 (Cav-3) expression is diminished after Trypanosoma cruzi infection: Cardiac
myocytes were isolated from mouse embryos and infected with trypomastigotes. Confocal
microscopy showed that uninfected cultures displayed abundant Cav-3 immunoreactivity
(A), including peripheral staining. Cav-3 signal was reduced among highly parasitized
myocytes (B) and was present predominantly at the cell periphery. DNA staining by DAPI
permitted visualization of host cell nucleus and the amastigote kinetoplastid DNA. Bars = 20
mm. Reproduced with permission from Adesse et al. Cell Cycle 2010; 9:1639–1649.81
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Table 1
Summary of papillomavirus entry pathways
HPV Type Pathway Identified Methods Used Ref.
BPV1 clathrin mediated entry, shuttling from
endosomes to caveosomes
biochemical inhibitors, colocalization studies, caveolin1
shRNA, dominant negative Cav-1, 293 cells, pseudovirions 27
BPV1/HPV16 clathrin mediated entry biochemical inhibitors, colocalization studies, C127 cells,
virions and VLPs 19
HPV16 clathrin/caveolae independent, lipid raft
independent, dynamin independent, tetraspanins
involved
siRNA KO of clathrin, cav1, dynamin and tetraspanins,
biochemical inhibitors, caveolin −/− cells, dominant negative
inhibitors 293TT and HELA cells, pseudovirions 23
HPV16 clathrin mediated entry, shuttling from
endosomes to caveosomes
biochemical inhibitors, colocalization studies, caveolinl
shRNA, HaCaT cells, pseudovirions 26
HPV16/HPV31 clathrin mediated entry (HPV16), caveolar uptake
(HPV31)
biochemical inhibitors, dominant negative inhibitors, HaCaT
cells, pseudovirions 22
HPV16/HPV31 clathrin mediated entry biochemical inhibitors, 293TT and COS7 cells,
pseudovirions 20
HPV31 Caveolar mediated uptake, Rab5 mediated
shuttling to endosome
biochemical inhibitors, colocalization studies, dominant
negative Rab5, HaCaT cells, pseudovirions 28
HPV16/31 and 58 clathrin mediated entry (HPV16 and 58) caveolar
uptake (HPV31)
biochemical inhibitors colocalization studies, COS7 cells,
VLPs and pseudovirions 18
HPV33 noncaveolar uptake biochemical inhibitors, COS7 and HELA cells, pseudovirions 21
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